Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax

[cafead]

via The race to nab the first FDA approval of an RSV vaccine is largely a two-horse sprint between Pfizer and GSK. But, in an interview with Fierce Biotech Tuesday, Moderna CEO Stéphane Bancel maintained confidence that his company's shot would stand out even as the development process lags months behind.

article source